Ozempic / GLP-1 Lawsuits Statistics in Phoenix
~1.65 million
City Population
~4.9 million
Metro Population
2 years from discovery
AZ SOL
Daubert
Expert Standard
Courts in Phoenix, Arizona
Maricopa County Superior Court
201 W Jefferson St, Phoenix, AZ 85003
U.S. District Court, District of Arizona
401 W Washington St, Phoenix, AZ 85003
Hospitals & Trauma Centers in Phoenix
Mayo Clinic Arizona — Gastroenterology
5777 E Mayo Blvd, Phoenix, AZ 85054
Banner University Medical Center Phoenix
1111 E McDowell Rd, Phoenix, AZ 85006
HonorHealth Scottsdale Osborn Medical Center
7400 E Osborn Rd, Scottsdale, AZ 85251
Liability Considerations in Phoenix
Ozempic Litigation in Phoenix
Phoenix-area GLP-1 prescriptions have surged in recent years, driven by the metro's large population and high demand for weight-loss medications. Mayo Clinic Arizona provides world-class gastroparesis diagnosis and treatment, including the gastric emptying studies that are now required evidence in the MDL. GLP-1 cases are consolidated in MDL 3094 (E.D. Pennsylvania) before Judge Karen S. Marston. Bellwether trials are expected in mid-to-late 2026. Phoenix claimants who developed gastroparesis, bowel obstruction, pancreatitis, or gallbladder disease after using Ozempic, Wegovy, or Mounjaro should compile pharmacy records and gastroenterology documentation promptly.